Plus   Neg

CVS Health Boosts FY20 Outlook - Quick Facts

While reporting financial results for the second quarter on Wednesday, CVS Health Corp. (CVS) raised its earnings and adjusted earnings guidance for the full-year 2020, reflecting an update to its estimated full year effective income tax rate.

For fiscal 2020, the company now projects earnings in a range of $5.59 to $5.72 per share and adjusted earnings in a range of $7.14 to $7.27 per share.

Previously, the company expected earnings in the range of $5.47 to $5.60 per share and adjusted earnings in the range of $7.04 to $7.17 per share.

On average, 26 analysts polled by Thomson Reuters expect the company to report earnings of $7.16 per share for the year. Analysts' estimates typically exclude special items.

The Company projects higher utilization in its Health Care Benefits segment in the second half of 2020 than in the first half of 2020 and continued significant COVID-19 related investments, including operating costs, in the remainder of the year.

Further, the company also raised its full year cash flow from operations guidance range to $11.0 billion to $11.5 billion from $10.5 billion to $11.0 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform U.S. airline Delta Air Lines, Inc. and its Italian codeshare partner Alitalia are planning to launch quarantine-free, COVID-free flights between U.S. and Europe through new testing protocols, starting in December. In a statement, Delta said it has signed deals with airports and governments eliminating quarantine requirements on COVID-tested flights connecting Atlanta and Rome.
Follow RTT